← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 28, 2017Last known activity
Nov 30, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 2 trials)
Phase 4 (3 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT06650956Lead sponsorN/ANov 30, 2024
- NCT06650956OfficialN/ANov 30, 2024
- NCT06650956Sponsor investigatorN/ANov 30, 2024
- NCT03783299CollaboratorPhase 4Nov 28, 2017
Details
- Last known activity
- Nov 30, 2024